CN103251832B - South radix isatidis traditional Chinese medicine formulation - Google Patents
South radix isatidis traditional Chinese medicine formulation Download PDFInfo
- Publication number
- CN103251832B CN103251832B CN201310191571.3A CN201310191571A CN103251832B CN 103251832 B CN103251832 B CN 103251832B CN 201310191571 A CN201310191571 A CN 201310191571A CN 103251832 B CN103251832 B CN 103251832B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title abstract description 7
- 239000010231 banlangen Substances 0.000 title abstract description 5
- 238000009472 formulation Methods 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 241000628997 Flos Species 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 7
- 241000555712 Forsythia Species 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- 238000005325 percolation Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 9
- 201000007100 Pharyngitis Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 201000009240 nasopharyngitis Diseases 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract 3
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 20
- 210000003026 hypopharynx Anatomy 0.000 description 19
- 230000006870 function Effects 0.000 description 16
- 239000003440 toxic substance Substances 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 5
- 208000027753 pain disease Diseases 0.000 description 5
- 201000000297 Erysipelas Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pure traditional Chinese medicine composite, and particularly relates to a south radix isatidis traditional Chinese medicine formulation for treating swollen sore throat caused by wind-heat type common cold. The south radix isatidis traditional Chinese medicine formulation comprises the following crude drugs in parts by weight: 20-150 parts of south radix isatidis, 20-100 parts of folium isatidis, 10-50 parts of mulberry leaves, 10-50 parts of flos lonicerae, 10-50 parts of fructus forsythiae, 10-50 parts of radix scutellariae, 10-50 parts of rhizoma phragmitis, 10-50 parts of radix bupleuri and 6-20 parts of radix sileris. Clinic indicates that the traditional Chinese medicine formulation disclosed by the invention can be used for treating the swollen sore throat caused by the wind-heat type common cold, achieves the non-rebounce rate more than 98% after being stopped for more than 60 days, achieves the effective rate by 98% by being taken by 500 patients without recrudescent phenomenon appearing at present after healing, has unique curative effect and higher healing rate on a swollen sore throat disease caused by the wind-heat type common cold and can be used for healing a general patient by needing only one treatment course without long-term medicine taking or obvious side effect.
Description
Technical field
The present invention relates to a kind of pure Traditional Chinese medicine composition, particularly a kind of Chinese medicine preparation of the Rhizoma Et Radix Baphicacanthis Cusiae that is used for the treatment of the laryngopharynx swelling and pain due to anemopyretic cold.
Background technology
Laryngopharynx swelling and pain disease due to anemopyretic cold is one of contemporary modal epidemic diseases, is that a kind of being detrimental to health affects human life quality's disease.
Laryngopharynx swelling and pain due at present treatment flu sick conventional be Chinese patent medicine, the laryngopharynx swelling and pain medicine due to conventional anemopyretic cold has following several:
1. antivirus oral liquid, function cures mainly: clearing heat and expelling damp, removing pathogenic heat from blood and toxic substance from the body.For anemopyretic cold, epidemic febrile disease heating and upper respiratory tract infection, the virus infectious diseases such as influenza, parotitis.The shortcoming that this medicine exists is: clinical symptoms is heavier, the course of disease is long or be associated with the patient that antibacterial infects, and should add other treatment medicine.
2. Radix Isatidis granule, function cures mainly: heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving.For laryngopharynx swelling and pain, pharyngoxerosis due to exuberant lung-stomach heat; Acute tonsillitis, parotitis are shown in above-mentioned patient.The shortcoming that this medicine exists is: hypertension, heart disease, hepatopathy, diabetes, nephropathy chronic diseases severe patient can not use.
3. YINQIAO JIEDU PIAN, function cures mainly: relieving the exterior syndrome with drugs of pungent in flavor and cool in nature, heat-clearing and toxic substances removing.For anemopyretic cold, fever and headache, cough, xerostomia, has sore throat.The shortcoming that this medicine exists is: quit smoking, wine and pungent, raw and cold, greasy food.Should not take nourishing Chinese medicine at period in a medicine simultaneously.Anemofrigid cold person is inapplicable.
4. detoxicating tablet of cow-bezoar, function cures mainly: heat-clearing and toxic substances removing.Contain laryngopharynx swelling and pain, gingival swelling and pain, aphtha of the mouth and tongue, conjunctival congestion and swelling pain in burning hot.The shortcoming that this medicine exists is: anemia of pregnant woman is forbidden neonate forbidding.
5. SUNJU GANMAO PIAN, function cures mainly: the shortcoming that wind and heat dispersing lung qi dispersing cough-relieving Tongrentang SUNJU GANMAO PIAN exists from the beginning of this medicine of headache cough xerostomia pharyngalgia for anemopyretic cold is: quit smoking, wine and pungent, raw and cold, greasy food.Should not take nourishing Chinese medicine at period in a medicine simultaneously.Anemofrigid cold person is inapplicable.
6. tablet of antelope horn for common cold, function cures mainly: clearing away heat and expelling pathogen in the exterior is shown in that for influenza disease the shortcoming of coughing fever and aversion to wind headache and dizzy this medicine of laryngopharynx swelling and pain uncomfortable in chest existing is: anemofrigid cold person is inapplicable.
7. tablet for treating common cold, function cures mainly: dispelling wind to relieve the exterior syndrome, heat-clearing and toxic substances removing.For anemopyretic cold, fever, headache, nasal obstruction watery nasal discharge, sneeze, laryngopharynx swelling and pain, the diseases such as systemic pain.The shortcoming that this medicine exists is: unsuitable steering vehicle, handle machine and work high above the ground etc. during medication.
Summary of the invention
The technical problem to be solved in the present invention is: a kind of determined curative effect is provided, is used for the treatment of the Chinese medicine preparation of the Rhizoma Et Radix Baphicacanthis Cusiae of the laryngopharynx swelling and pain due to anemopyretic cold, solved above-mentioned problems of the prior art.
The technical scheme solving the problems of the technologies described above is: a kind of Chinese medicine preparation of Rhizoma Et Radix Baphicacanthis Cusiae, and its various raw material medicines in portions by weight are counted proportioning and are:
20～150 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20～100 parts of Folium Isatidiss, 10～50 parts, Folium Mori,
10～50 parts of Flos Lonicerae, 10～50 parts of Fructus Forsythiaes, 10～50 parts of Radix Scutellariaes,
10～50 parts of Rhizoma Phragmitiss, 10～50 parts of Radix Bupleuri, 6～20 parts of Radix Saposhnikoviaes.
The Chinese medicine preparation of described a kind of Rhizoma Et Radix Baphicacanthis Cusiae, its various raw material medicines in portions by weight are counted proportion optimization and are:
40～80 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20～50 parts of Folium Isatidiss, 10～30 parts, Folium Mori,
10～50 parts of Flos Lonicerae, 10～30 parts of Fructus Forsythiaes, 10～30 parts of Radix Scutellariaes,
10～30 parts of Rhizoma Phragmitiss, 10～30 parts of Radix Bupleuri, 6～10 parts of Radix Saposhnikoviaes.
The Chinese medicine preparation of described a kind of Rhizoma Et Radix Baphicacanthis Cusiae, its various raw material medicines in portions by weight are counted proportion optimization and are:
50 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20 parts of Folium Isatidiss, 10 parts, Folium Mori,
20 parts of Flos Lonicerae, 20 parts of Fructus Forsythiaes, 10 parts of Radix Scutellariaes,
10 parts of Rhizoma Phragmitiss, 10 parts of Radix Bupleuri, 6 parts of Radix Saposhnikoviaes.
In the present invention, the characteristic of various crude drug is as follows:
The function of Rhizoma Et Radix Baphicacanthis Cusiae cures mainly: heat-clearing and toxic substances removing; Removing heat from blood detumescence.Cure mainly maculae caused by violent heat pathogen; High heat headache; Major part pestilence; Erysipelas; Mumps; Viral hepatitis; Influenza; Pneumonia; Skin ulcer is swollen; Herpes.
Folium Isatidis function cures mainly; Heat clearing away, removing toxic substances, removing heat from blood, hemostasis.Control epidemic febrile disease intenseness of heat excessive thirst, influenza, acute infectious hepatitis, bacillary dysentery, acute gastroenteritis, acute pneumonia, erysipelas, spits blood, epistaxis, jaundice, dysentery, sore throat, aphtha, swollen ulcer drug.
The function of Folium Mori cures mainly: expelling wind and clearing away heat, cooling blood for improving eyesight.Control pathogenic wind-warm heating, headache, conjunctival congestion, thirsty, cough due to lung-heat, migratory arthralgia, urticaria, lower limb elephatiasis.
Flos Lonicerae function with cure mainly: heat-clearing and toxic substances removing, dispelling wind and heat pathogens.Treat skin ulcer, sore throat, erysipelas, toxic-heat and blood stasis, anemopyretic cold, epidemic febrile disease for carbuncle.
The function of Fructus Forsythiae cures mainly: heat clearing away, removing toxic substances, eliminating stagnation, detumescence.Control warm, erysipelas, macule, carbuncle and ulcer toxic swelling, scrofula, urine stranguria with urinary obstruction.
The function of Radix Scutellariae cures mainly: heat clearing and damp drying, and eliminating fire and detoxication, hemostasis, antiabortive.For hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.
The function of Rhizoma Phragmitis cures mainly: clearing away heat and promoting production of body fluid, lung moistening stomach function regulating, relieves restlessness and prevents vomiting.Treatment gastric heat halitosis, gastric heat excessive thirst, vomiting etc.
The function of Radix Bupleuri cures mainly: evacuate and bring down a fever, yang invigorating soothing liver-QI.For cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, uterus comes off, menoxenia.
The function of Radix Saposhnikoviae cures mainly: deliver, dispel the wind, victory is wet, pain relieving.Control affection of exogenous wind-cold, headache, dizzy, stiffness of the nape, anemofrigid-damp arthralgia, joint is ached, and extremity contraction is anxious, tetanus.
Anemopyretic cold is due to evil criminal's table, the lung qi of wind heat become estranged.Symptoms for heating weight, micro evil wind, distending pain in the head, have that antiperspirant, red swelling and pain of throat, cough, expectorant are sticky or yellow, the yellow thick nasal discharge of having a stuffy nose, thirst and liking drink, the tip of the tongue limit are red, the micro-Huang of white and thin fur.Anemopyretic cold is more common in summer and autumn, due to affection due to external wind and heat.The traditional Chinese medical science thinks, anemopyretic cold is the exterior syndrome of experiencing due to the heresy of wind heat.
The general symptom of anemopyretic cold is as follows: 1. sore throat, and pain just before cold symptoms conventionally, expectorant is yellow or band black conventionally.2. dense tears, conventionally yellow.3. tongue fur band point is yellow, is likely also white, and tongue body is conventionally redder.4. constipation.5. fever of the body, thirsty, vexed.6. vein is generally rapid pulse or full pulse, is exactly that pulse ratio is normally for fast, for greatly.
Infantile anemopyretic cold main manifestations is heavy for fever, but the aversion to wind of being afraid of cold is not obvious, and the turbid tears of nose choked flow, cough low voice speaking, or have sticky yellow sputum, and headache, thirst and liking drink, pharynx are red, dry pharynx or sufferings.Large dry stool, yellow urine, checks visible tonsil redness, pharyngeal congestion, tongue fur BOHUANG or yellow thick, red tongue, floating pulse and fast.
Anemopyretic cold, the normally constipation of its cause, belongs to Yangming Channel disease when a lot of.Normal conditions are such, and constipation is after two days, sore throat a couple of days, then develop signs of a cold, Here it is anemopyretic cold (can be also diseases caused by exogenous pathogenic factor pathogenic heat, attacking the lung first).
The Chinese medicine preparation of a kind of Rhizoma Et Radix Baphicacanthis Cusiae of the present invention, has effect of heat-clearing and toxic substances removing, and clinical showing, this Chinese medicine preparation can be used in the laryngopharynx swelling and pain disease due to treatment anemopyretic cold, and drug withdrawal does not rebound rate for 60 days above more than 98%.The present invention takes through 500 patients, and effective percentage has reached 98%, after curing, has not seen the phenomenon that has recurrence at present.The present invention has unique curative effect and higher cure rate to the laryngopharynx swelling and pain disease due to treatment anemopyretic cold, the laryngopharynx swelling and pain of taking due to medicine anemopyretic cold on the same day of the present invention obviously turns light, general patient only needs to cure a course for the treatment of, without Long-term taking medicine, without significantly side effect.
Detailed description of the invention
Embodiment mono-:
A Chinese medicine preparation for Rhizoma Et Radix Baphicacanthis Cusiae, its various raw material medicines in portions by weight are counted proportioning and are: monarch drug Rhizoma Et Radix Baphicacanthis Cusiae 60g, ministerial drug Folium Isatidis 30g, ministerial drug Folium Mori 30g, ministerial drug Flos Lonicerae 20 g, ministerial drug ministerial drug Fructus Forsythiae 20 g, ministerial drug Radix Scutellariae 10 g, ministerial drug Rhizoma Phragmitis 10 g, ministerial drug Radix Bupleuri 10 g, ministerial drug Radix Saposhnikoviae 6 g.
The preparation method of above-mentioned Chinese medicine preparation is:
The former spice of above nine taste, carry out percolation as solvent with 70% ethanol, collect percolate, percolate reclaims ethanol and is concentrated into the thick paste that 70～80 DEG C of relative densities are 1.26-1.2, and thick paste adds water 6 times to measure and decocts 2 hours, filters medicinal liquid and is concentrated into the thick paste that 70～80 DEG C of relative densities are 1.26-1.28, adding ethanol makes to reach 60% containing alcohol amount, leave standstill 24 hours, get supernatant, reclaim ethanol and be concentrated into the thick paste that 80 DEG C of relative densities are 1.26-1.28; Thick paste and appropriate starch granulation, obtain granular product after being dried.If desired bulk product,, after granulation, is dried and mixes, and briquetting, to obtain final product.
Embodiment bis-～embodiment seven:
A Chinese medicine preparation for Rhizoma Et Radix Baphicacanthis Cusiae, the crude drug of said composition and parts by weight refer to subordinate list one, and the preparation method of this Chinese medicine composition is identical with embodiment mono-.
Subordinate list one
Below by clinical trial case case, curative effect of the present invention is described further.
1. patient Luo, female, 30 years old, the laryngopharynx swelling and pain disease due to anemopyretic cold.Use sick an improvement of the laryngopharynx swelling and pain course for the treatment of after medicine of the present invention, after three courses for the treatment of, return to one's perfect health, now within 8 months, loseed recurrence.
2. patient Li Xiansheng, man, 40 years old, the sick medication of the laryngopharynx swelling and pain rehabilitation after 10 days due to anemopyretic cold, loseed recurrence for 11 months after drug withdrawal.
3. patient Deng Xiansheng, man, 45 years old, the laryngopharynx swelling and pain disease due to anemopyretic cold, was used the present invention, after the course for the treatment of of taking medicine, returns to one's perfect health, and has now loseed recurrence half a year.
4. patient's Mr. Wang, man, 48 years old, use a course for the treatment of of the present invention, the sick recovery from illness of laryngopharynx swelling and pain due to anemopyretic cold, now loses recurrence 1 year.
5. patient Zheng Xiansheng, man, 28 years old, use a course for the treatment of of the present invention, the sick recovery from illness of laryngopharynx swelling and pain due to anemopyretic cold, does not now recur more than 1 year after drug withdrawal.
6. patient Mrs Lin Zhong, 38 years old, use a course for the treatment of of the present invention, the sick recovery from illness of laryngopharynx swelling and pain due to anemopyretic cold, does not now recur after drug withdrawal for 11 months.
Claims (3)
1. a Chinese medicine preparation for Rhizoma Et Radix Baphicacanthis Cusiae, is characterized in that: its various raw material medicines in portions by weight are counted proportioning and are:
20～150 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20～100 parts of Folium Isatidiss, 10～50 parts, Folium Mori,
10～50 parts of Flos Lonicerae, 10～50 parts of Fructus Forsythiaes, 10～50 parts of Radix Scutellariaes,
10～50 parts of Rhizoma Phragmitiss, 10～50 parts of Radix Bupleuri, 6～20 parts of Radix Saposhnikoviaes,
The preparation method of above-mentioned Chinese medicine preparation is:
The former spice of above nine taste, carry out percolation as solvent with 70% ethanol, collect percolate, percolate reclaims ethanol and is concentrated into the thick paste that 70～80 DEG C of relative densities are 1.26-1.2, and thick paste adds water 6 times to measure and decocts 2 hours, filters medicinal liquid and is concentrated into the thick paste that 70～80 DEG C of relative densities are 1.26-1.28, adding ethanol makes to reach 60% containing alcohol amount, leave standstill 24 hours, get supernatant, reclaim ethanol and be concentrated into the thick paste that 80 DEG C of relative densities are 1.26-1.28; Thick paste and appropriate starch granulation, obtain granular product after being dried.
2. the Chinese medicine preparation of a kind of Rhizoma Et Radix Baphicacanthis Cusiae according to claim 1, is characterized in that: its various raw material medicines in portions by weight are counted proportioning and are:
40～80 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20～50 parts of Folium Isatidiss, 10～30 parts, Folium Mori,
10～50 parts of Flos Lonicerae, 10～30 parts of Fructus Forsythiaes, 10～30 parts of Radix Scutellariaes,
10～30 parts of Rhizoma Phragmitiss, 10～30 parts of Radix Bupleuri, 6～10 parts of Radix Saposhnikoviaes.
3. the Chinese medicine preparation of a kind of Rhizoma Et Radix Baphicacanthis Cusiae according to claim 2, is characterized in that: its various raw material medicines in portions by weight are counted proportioning and are:
50 parts of Rhizoma Et Radix Baphicacanthis Cusiaes, 20 parts of Folium Isatidiss, 10 parts, Folium Mori,
20 parts of Flos Lonicerae, 20 parts of Fructus Forsythiaes, 10 parts of Radix Scutellariaes,
10 parts of Rhizoma Phragmitiss, 10 parts of Radix Bupleuri, 6 parts of Radix Saposhnikoviaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310191571.3A CN103251832B (en) | 2013-05-22 | 2013-05-22 | South radix isatidis traditional Chinese medicine formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310191571.3A CN103251832B (en) | 2013-05-22 | 2013-05-22 | South radix isatidis traditional Chinese medicine formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103251832A CN103251832A (en) | 2013-08-21 |
| CN103251832B true CN103251832B (en) | 2014-11-26 |
Family
ID=48956265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310191571.3A Active CN103251832B (en) | 2013-05-22 | 2013-05-22 | South radix isatidis traditional Chinese medicine formulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103251832B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813849A (en) * | 2005-12-08 | 2006-08-09 | 王金政 | Medicine for treating common cold and its preparing method |
| CN101474317A (en) * | 2009-02-01 | 2009-07-08 | 卢爱民 | Method for preparing Chinese medicine for treating wind-heat excess type blepharitis |
| CN101601830A (en) * | 2009-07-10 | 2009-12-16 | 卢速江 | A kind of Chinese medicine preparation for the treatment of flu and preparation method thereof |
| CN101780248A (en) * | 2010-03-04 | 2010-07-21 | 胡荣光 | Chinese herbal medicine compound for preventing flu |
-
2013
- 2013-05-22 CN CN201310191571.3A patent/CN103251832B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1813849A (en) * | 2005-12-08 | 2006-08-09 | 王金政 | Medicine for treating common cold and its preparing method |
| CN101474317A (en) * | 2009-02-01 | 2009-07-08 | 卢爱民 | Method for preparing Chinese medicine for treating wind-heat excess type blepharitis |
| CN101601830A (en) * | 2009-07-10 | 2009-12-16 | 卢速江 | A kind of Chinese medicine preparation for the treatment of flu and preparation method thereof |
| CN101780248A (en) * | 2010-03-04 | 2010-07-21 | 胡荣光 | Chinese herbal medicine compound for preventing flu |
Non-Patent Citations (6)
| Title |
|---|
| 叶进等.近20年中医药防治流感的进展.《中华中医药学刊》.2009,第27卷(第4期),799-801. * |
| 外感与常见肺系疾病的中医诊断及治疗;王光辉等;《社区医学杂志》;20051231;第3卷(第4期);29-34 * |
| 治疗感冒的常用中成药;老甘;《中老年保健》;20070331;38 * |
| 王光辉等.外感与常见肺系疾病的中医诊断及治疗.《社区医学杂志》.2005,第3卷(第4期),29-34. * |
| 老甘.治疗感冒的常用中成药.《中老年保健》.2007,38. * |
| 近20年中医药防治流感的进展;叶进等;《中华中医药学刊》;20090430;第27卷(第4期);799-801 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103251832A (en) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526355A (en) | Chinese medicinal compound preparation for resisting virus and treating flu and cold | |
| CN105412749A (en) | Medicine for treating infantile pneumonia with dyspnea and cough and preparation method and application method thereof | |
| CN103169885A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN104436150A (en) | Traditional Chinese medicine composition used for treating rhinitis | |
| CN1931262B (en) | Common cold treating Chinese medicine preparation | |
| CN103920016A (en) | Chinese medicinal tea for treating chronic sphagitis | |
| CN103251832B (en) | South radix isatidis traditional Chinese medicine formulation | |
| CN106620205A (en) | Externally-used traditional Chinese medicine for foot bath to treat pediatric fever | |
| CN102429979A (en) | Traditional Chinese medicine composition for treating cold and preparation method thereof | |
| CN102688405B (en) | Bulbus fritillariae cirrhosae traditional Chinese medicine decoction for treating cough and preparation method | |
| CN104147334A (en) | Traditional Chinese medicine formula capable of eliminating phlegm | |
| CN104474256A (en) | Oral liquor for treating acquired immunodeficiency syndrome lung infection | |
| CN104666961A (en) | Traditional Chinese medicine for treating aphtha | |
| CN102058792A (en) | Traditional Chinese medicine preparation for treatment of cold and cough | |
| CN102429982A (en) | Traditional Chinese medicine granules for treating cold and preparation method thereof | |
| CN1237999C (en) | Medicine for treating wind-warm lung-heat illness of children | |
| CN106511812A (en) | Medicine for treating common cold and preparation method of medicine | |
| CN105168813A (en) | Exterior syndrome relieving and internal heat and detoxication relieving soup | |
| CN105147856A (en) | Traditional Chinese medicine composition used for treating infantile acute laryngitis | |
| CN104922525A (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| CN104306489A (en) | Anemopyretic cold dispersible tablets and preparation method thereof | |
| CN104435133A (en) | Medicament for reducing fever | |
| CN103800860A (en) | Medicine for treating wind-cold type common cold and preparation method thereof | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: South radix isatidis traditional Chinese medicine formulation Effective date of registration: 20160608 Granted publication date: 20141126 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: 2016450000007 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210304 Granted publication date: 20141126 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: 2016450000007 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine preparation of Radix Isatidis Effective date of registration: 20210510 Granted publication date: 20141126 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: Y2021450000015 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220513 Granted publication date: 20141126 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: Y2021450000015 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Traditional Chinese Medicine Preparation of Nanban Langen Effective date of registration: 20230421 Granted publication date: 20141126 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: Y2023450000063 |